Literature DB >> 8614306

Dietary lipid modification of myocardial eicosanoids following ischemia and reperfusion in the rat.

M Y Abeywardena1, J S Charnock.   

Abstract

Several different edible oils were compared for their ability to modify eicosanoid biosynthesis following experimentally-induced myocardial ischemia and reperfusion in the rat. Two types of palm oil [neutralized, bleached, and deodorized (NBDPO) and refined, bleached, and deodorized (RBDPO)] and partially hydrogenated soybean oil (SBO) were tested against a diet supplemented with sunflower seed oil (SSO) rich in n-6 polyunsaturated fatty acids (PUFA). Fish oil (FO) rich in n-3 PUFA, with its known cardioprotective actions, served as an internal reference point for the study. Test oils were fed as a 12% (w/w) supplement for nine months before the induction of myocardial ischemia and reperfusion. Palm oil diets exerted effects indistinguishable from the SBO group against cardiac arrhythmia, which occurred following alterations to coronary blood flow. Arrhythmic potentials, as expressed by a hierarchical scale (0-9) of arrhythmia score, were: SSO, 1.5 +/- 0.5; FO, 0.9 +/- 0.4; SBO, 3.1 +/- 0.5*; NBDPO, 3.2 +/- 0.5*; RBDPO, 3.3 +/- 0.6*; *P < 0.05 vs. SSO. Following ischemia and reperfusion, both SSO and RBDPO groups tended to show an increase in myocardial prostacyclin, with the effect being more prominent in the RBDPO group (SSO, 10%; RBDPO, 25%). Thromboxane production was reduced in the FO group. Interestingly, cardiac muscle from both FO and palm oil groups displayed a reduced capacity to produce 12-hydroxyeicosatetraenoic acid SSO, 591 +/- 95.8; SBO, 375.5 +/- 48.9; NBDPO, 287.2 +/- 64.7*; RBDPO, 230.9 +/- 80.2**; FO, 203.7 +/- 81.4** (ng/g dry wt, *P < 0.05, **P < 0.01). No clear relationship was seen between the availability of 20:4n-6 in myocardial phospholipids and eicosanoid profile. Data suggests that fatty acid composition of edible oils is not the only determinant of arrhythmic vulnerability and eicosanoid production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8614306     DOI: 10.1007/bf02536617

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  23 in total

Review 1.  The role of vitamin E and selenium on arachidonic acid oxidation by way of the 5-lipoxygenase pathway.

Authors:  P Reddanna; J Whelan; J R Burgess; M L Eskew; G Hildenbrandt; A Zarkower; R W Scholz; C C Reddy
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

2.  Reperfusion-induced arrhythmias: mechanisms and prevention.

Authors:  A S Manning; D J Hearse
Journal:  J Mol Cell Cardiol       Date:  1984-06       Impact factor: 5.000

Review 3.  Endogenous myocardial protective (antiarrhythmic) substances.

Authors:  J Parratt
Journal:  Cardiovasc Res       Date:  1993-05       Impact factor: 10.787

4.  Vitamin E and ventricular fibrillation threshold in myocardial ischemia.

Authors:  A J Fuenmayor; A M Fuenmayor; T López; D M Winterdaal
Journal:  Jpn Circ J       Date:  1989-10

5.  On the mechanism of antithrombotic action of flavonoids.

Authors:  R J Gryglewski; R Korbut; J Robak; J Swies
Journal:  Biochem Pharmacol       Date:  1987-02-01       Impact factor: 5.858

Review 6.  Lipids and cardiac arrhythmia.

Authors:  J S Charnock
Journal:  Prog Lipid Res       Date:  1994       Impact factor: 16.195

7.  Comparative changes in the fatty-acid composition of rat cardiac phospholipids after long-term feeding of sunflower seed oil- or tuna fish oil-supplemented diets.

Authors:  J S Charnock; M Y Abeywardena; P L McLennan
Journal:  Ann Nutr Metab       Date:  1986       Impact factor: 3.374

8.  Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia.

Authors:  M J Curtis; M J Walker
Journal:  Cardiovasc Res       Date:  1988-09       Impact factor: 10.787

9.  The composition of cardiac phospholipids in rats fed different lipid supplements.

Authors:  J S Charnock; M Y Abeywardena; E J McMurchie; G R Russell
Journal:  Lipids       Date:  1984-03       Impact factor: 1.880

Review 10.  Free radical scavengers in myocardial ischemia.

Authors:  P J Simpson; J K Mickelson; B R Lucchesi
Journal:  Fed Proc       Date:  1987-05-15
View more
  6 in total

1.  Dietary fish oil dose-response effects on ileal phospholipid fatty acids and contractility.

Authors:  Glen S Patten; Michael J Adams; Julie A Dallimore; Mahinda Y Abeywardena
Journal:  Lipids       Date:  2005-09       Impact factor: 1.880

Review 2.  Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death.

Authors:  P L McLennan; M Y Abeywardena
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

3.  Dietary menhaden, seal, and corn oils differentially affect lipid and ex vivo eicosanoid and thiobarbituric acid-reactive substances generation in the guinea pig.

Authors:  M G Murphy; V Wright; J Scott; A Timmins; R G Ackman
Journal:  Lipids       Date:  1999-02       Impact factor: 1.880

Review 4.  Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids.

Authors:  Peter L McLennan
Journal:  Eur J Appl Physiol       Date:  2014-04-04       Impact factor: 3.078

5.  Positive outcomes of oil palm phenolics on degenerative diseases in animal models.

Authors:  Ravigadevi Sambanthamurthi; YewAi Tan; Kalyana Sundram; Kenneth C Hayes; Mahinda Abeywardena; Soon-Sen Leow; Shamala Devi Sekaran; T G Sambandan; ChoKyun Rha; Anthony J Sinskey; Krishnan Subramaniam; Syed Fairus; Mohd Basri Wahid
Journal:  Br J Nutr       Date:  2011-06-07       Impact factor: 3.718

6.  Rise in DPA Following SDA-Rich Dietary Echium Oil Less Effective in Affording Anti-Arrhythmic Actions Compared to High DHA Levels Achieved with Fish Oil in Sprague-Dawley Rats.

Authors:  Mahinda Y Abeywardena; Michael Adams; Julie Dallimore; Soressa M Kitessa
Journal:  Nutrients       Date:  2016-01-04       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.